ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Chlorotrimethylsilane → (S)-3-{3-Benzyloxy-4-[1,1,4-trioxo-5-(2-trimethylsilanylethyl)-1,2,5-thiadiazolidin-2-yl]-phenyl}-2-tert-butoxycarbonylaminopropionic Acid Tert-butyl Ester

HRID 660634
印刷

反応式

HRID 660634 の反応式
Cl[Si](C)(C)C.[C:6]([O:10][C:11](=[O:23])[C@@H:12]([NH:15][C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:13]I)([CH3:9])([CH3:8])[CH3:7].[CH2:24]([O:31][C:32]1[CH:37]=[C:36](I)[CH:35]=[CH:34][C:33]=1[N:39]1[S:43](=[O:45])(=[O:44])[N:42]([CH2:46][CH2:47][Si:48]([CH3:51])([CH3:50])[CH3:49])[C:41](=[O:52])[CH2:40]1)[C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1.C1(C)C=CC=CC=1P(C1C=CC=CC=1C)C1C=CC=CC=1C>CN(C=O)C.[Zn].C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].O>[C:6]([O:10][C:11](=[O:23])[C@@H:12]([NH:15][C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:13][C:36]1[CH:35]=[CH:34][C:33]([N:39]2[CH2:40][C:41](=[O:52])[N:42]([CH2:46][CH2:47][Si:48]([CH3:51])([CH3:50])[CH3:49])[S:43]2(=[O:45])=[O:44])=[C:32]([O:31][CH2:24][C:25]2[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=2)[CH:37]=1)([CH3:9])([CH3:8])[CH3:7]
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 4

HCID 6397ChlorotrimethylsilaneHCID 80271Tri-o-tolylphosphineHCID 54762716(R)-2-tert-butoxycarbonylamino-3-iodopropionic acid tert-butyl esterHCID 667569375-(2-Benzyloxy-4-iodophenyl)-1,1-dioxo-2-(2-trimethylsilanylethyl)-1,2,5-thiadiazolidin-3-one

生成物 1

HCID 68840018
(S)-3-{3-Benzyloxy-4-[1,1,4-trioxo-5-(2-trimethylsilanylethyl)-1,2,5-thiadiazolidin-2-yl]-phenyl}-2-tert-butoxycarbonylaminopropionic Acid Tert-butyl Ester

試薬・触媒・溶媒 4

HCID 23994Zinc触媒HCID 9811564Bis(dibenzylideneacetone)palladium触媒HCID 962Water溶媒HCID 6228Dimethylformamide溶媒3 回

実験手順

To a suspension of zinc powder (645 mg, 9.9 mmol) in DMF (1 mL) under argon is added chlorotrimethylsilane (83 mg, 0.76 mmol) and the mixture is stirred at RT for 30 min. To this is added a solution of (R)-2-tert-butoxycarbonylamino-3-iodopropionic acid tert-butyl ester (1.1 g, 2.96 mmol) in DMF (1.8 mL) dropwise and the mixture is stirred at RT for 30 min. An additional 2.5 mL of DMF is added and any insoluble material is filtered. The filtrate is added to a mixture of 5-(2-benzyloxy-4-iodophenyl)-1,1-dioxo-2-(2-trimethylsilanylethyl)-1,2,5-thiadiazolidin-3-one (900 mg, 1.65 mmol), tri-o-tolylphosphine (100 mg, 0.33 mmol) and Pd2(dba)3 (74 mg, 0.08 mmol) and the mixture is stirred at RT for 90 min. Water is added and the mixture is extracted with EtOAc. The organic phase is washed with water (2×) and brine then is dried over sodium sulfate. The solvent is remover under reduced pressure and the residue is purified by flash chromatography using EtOAc/hexane (10%) as eluent to give the title compound as an off-white solid.

後処理

  1. stirringthe mixture is stirred at RT for 30 min
  2. filtrationany insoluble material is filtered
  3. stirringthe mixture is stirred at RT for 90 min
  4. extractionthe mixture is extracted with EtOAc
  5. washThe organic phase is washed with water (2×) and brine
  6. dry with materialthen is dried over sodium sulfate
  7. customthe residue is purified by flash chromatography

出典と根拠

ORDレコード
ord-05dd9d8117dc4be4a8c02d3792c3dffd
出典データセット
uspto-grants-2011_12
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08084448B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート